MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the 31 st annual Transcatheter ...

Company expands structural heart portfolio and begins the limited market release of a bipolar temporary pacing guidewire intended to introduce and position catheters and other interventional devices ...

MENLO PARK, Calif.--(BUSINESS WIRE)--BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo ® Lead has obtained CE Mark certification in ...

WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the Wattson™ Temporary Pacing Guidewire ...

Teleflex Incorporated TFX received the FDA’s 510(k) clearance for its bipolar temporary pacing guidewire — Wattson Temporary Pacing Guidewire. Per Teleflex, the device will be the first commercially ...

Teleflex Incorporated TFX recently announced the receipt of the FDA clearance for Wattson Temporary Pacing Guidewire. The company will feature Wattson at TVT — The Structural Heart Summit between Jun ...

The global temporary pacing leads market is poised for significant growth, with sales estimated at USD 369.79 million in 2024 and projected to reach USD 519.56 million by 2034. This market expansion ...

Teleflex Incorporated TFX received the FDA’s 510(k) clearance for its bipolar temporary pacing guidewire — Wattson Temporary Pacing Guidewire. Per Teleflex, the device will be the first commercially ...

MarketsandResearch.biz has recently published a research report titled Global Temporary Cardiac Pacing Leads Market Growth 2021-2026 that comprises wide-broadening quantifiable facts of the market.

Temporary pacing leads are getting more stage time as doctors try to head off a common heart block complication from TAVR. BioTrace Medical Inc.'s new Tempo lead aims to make temporary pacing more ...